Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
Abstract Objective To evaluate the diagnostic efficacy of 18F-AlF-NOTA-octreotide (18F-OC) PET/CT compared with that of 68Ga-DOTATATE PET/CT. Materials and methods Twenty patients (mean age: 52.65 years, range: 24–70 years) with biopsy-proven neuroendocrine neoplasms (NENs) were enrolled in this pro...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-06-01
|
Series: | EJNMMI Research |
Online Access: | https://doi.org/10.1186/s13550-021-00797-4 |
id |
doaj-3fe331ed0f334de3a82ab5a8e057eae1 |
---|---|
record_format |
Article |
spelling |
doaj-3fe331ed0f334de3a82ab5a8e057eae12021-06-13T11:29:09ZengSpringerOpenEJNMMI Research2191-219X2021-06-011111910.1186/s13550-021-00797-4Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CTJiale Hou0Tingting Long1Zhiyou He2Ming Zhou3Nengan Yang4Dengming Chen5Shan Zeng6Shuo Hu7Department of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityDepartment of Cancer Chemotherapy, XiangYa Hospital, Central South UniversityDepartment of Nuclear Medicine, XiangYa Hospital, Central South UniversityAbstract Objective To evaluate the diagnostic efficacy of 18F-AlF-NOTA-octreotide (18F-OC) PET/CT compared with that of 68Ga-DOTATATE PET/CT. Materials and methods Twenty patients (mean age: 52.65 years, range: 24–70 years) with biopsy-proven neuroendocrine neoplasms (NENs) were enrolled in this prospective study. We compared the biodistribution profiles in normal organs based on the maximum standard uptake value (SUVmax) and mean standard uptake value (SUVmean), and uptake in NEN lesions by measuring the SUVmax on 18F-OC and 68Ga-DOTATATE PET/CT images. The tumor-to-liver ratio (TLR) and tumor-to-spleen ratio were calculated by dividing the SUVmax of different tumor lesions by the SUVmean of the liver and spleen, respectively. The Wilcoxon signed-rank test was used to compare nonparametric data. Data were expressed as the median (interquartile range). Results In most organs, there were no significant differences in the biodistribution of 68Ga-DOTATATE and 18F-OC. 18F-OC had significantly lower uptake in the salivary glands and liver than 68Ga-DOTATATE. 18F-OC detected more lesions than 68Ga-DOTATATE. The uptake of 18F-OC in the tumors was higher in most patients, but the difference was not statistically significant relative to that of 68Ga-DOTATATE. However, the TLRs of 18F-OC were higher in most patients, including for lesions in the liver (p = 0.02) and lymph nodes (p = 0.02). Conclusion Relative to 68Ga-DOTATATE, 18F-OC possesses favorable characteristics with similar image quality and satisfactory NEN lesion detection rates, especially in the liver due to its low background uptake. 18F-OC therefore offers a promising clinical alternative for 68Ga-DOTATATE.https://doi.org/10.1186/s13550-021-00797-4 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jiale Hou Tingting Long Zhiyou He Ming Zhou Nengan Yang Dengming Chen Shan Zeng Shuo Hu |
spellingShingle |
Jiale Hou Tingting Long Zhiyou He Ming Zhou Nengan Yang Dengming Chen Shan Zeng Shuo Hu Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT EJNMMI Research |
author_facet |
Jiale Hou Tingting Long Zhiyou He Ming Zhou Nengan Yang Dengming Chen Shan Zeng Shuo Hu |
author_sort |
Jiale Hou |
title |
Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT |
title_short |
Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT |
title_full |
Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT |
title_fullStr |
Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT |
title_full_unstemmed |
Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT |
title_sort |
evaluation of 18f-alf-nota-octreotide for imaging neuroendocrine neoplasms: comparison with 68ga-dotatate pet/ct |
publisher |
SpringerOpen |
series |
EJNMMI Research |
issn |
2191-219X |
publishDate |
2021-06-01 |
description |
Abstract Objective To evaluate the diagnostic efficacy of 18F-AlF-NOTA-octreotide (18F-OC) PET/CT compared with that of 68Ga-DOTATATE PET/CT. Materials and methods Twenty patients (mean age: 52.65 years, range: 24–70 years) with biopsy-proven neuroendocrine neoplasms (NENs) were enrolled in this prospective study. We compared the biodistribution profiles in normal organs based on the maximum standard uptake value (SUVmax) and mean standard uptake value (SUVmean), and uptake in NEN lesions by measuring the SUVmax on 18F-OC and 68Ga-DOTATATE PET/CT images. The tumor-to-liver ratio (TLR) and tumor-to-spleen ratio were calculated by dividing the SUVmax of different tumor lesions by the SUVmean of the liver and spleen, respectively. The Wilcoxon signed-rank test was used to compare nonparametric data. Data were expressed as the median (interquartile range). Results In most organs, there were no significant differences in the biodistribution of 68Ga-DOTATATE and 18F-OC. 18F-OC had significantly lower uptake in the salivary glands and liver than 68Ga-DOTATATE. 18F-OC detected more lesions than 68Ga-DOTATATE. The uptake of 18F-OC in the tumors was higher in most patients, but the difference was not statistically significant relative to that of 68Ga-DOTATATE. However, the TLRs of 18F-OC were higher in most patients, including for lesions in the liver (p = 0.02) and lymph nodes (p = 0.02). Conclusion Relative to 68Ga-DOTATATE, 18F-OC possesses favorable characteristics with similar image quality and satisfactory NEN lesion detection rates, especially in the liver due to its low background uptake. 18F-OC therefore offers a promising clinical alternative for 68Ga-DOTATATE. |
url |
https://doi.org/10.1186/s13550-021-00797-4 |
work_keys_str_mv |
AT jialehou evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct AT tingtinglong evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct AT zhiyouhe evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct AT mingzhou evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct AT nenganyang evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct AT dengmingchen evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct AT shanzeng evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct AT shuohu evaluationof18falfnotaoctreotideforimagingneuroendocrineneoplasmscomparisonwith68gadotatatepetct |
_version_ |
1721379761481056256 |